Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-02-28 Sale | 2025-02-28 5:19 pm | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 1,938 | $34 | $65,892 | 15,957 (Direct) | View |
| 2025-02-25 Sale | 2025-02-25 6:38 pm | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 3,743 | $35.26 | $131,978 | 12,284 (Direct) | View |
| 2025-02-20 Sale | 2025-02-20 5:18 pm | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 1,327 | $35.69 | $47,361 | 34,003 (Direct) | View |
| 2025-02-12 Sale | 2025-02-14 5:12 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 349,340 | $33.92 | $11,848,975 | 179,151 (Direct) | View |
| 2025-01-30 Sale | 2025-01-31 8:42 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 100,918 | $32.05 | $3,234,382 | 492,619 (Direct) | View |
| 2024-12-09 Sale | 2024-12-09 8:53 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 61,151 | $32.07 | $1,961,406 | 593,537 (Direct) | View |
| 2024-12-09 Sale | 2024-12-09 8:51 pm | Alkermes plc. | ALKS | LAURENCIN CATO T Director | 2,691 | $31.85 | $85,708 | 39,155 (Direct) | View |
| 2024-12-05 Sale | 2024-12-05 6:01 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 9,221 | $31.5 | $290,462 | 59,730 (Direct) | View |
| 2024-12-04 Sale | 2024-12-04 4:52 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 14,349 | $30.77 | $441,550 | 68,951 (Direct) | View |
| 2024-11-27 Sale | 2024-11-27 4:22 pm | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 5,208 | $29.15 | $151,813 | 60,703 (Direct) | View |
| 2024-11-11 Sale | 2024-11-12 4:48 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 58,996 | $30.08 | $1,774,576 | 212,474 (Direct) | View |
| 2024-11-06 Sale | 2024-11-06 7:47 pm | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 10,471 | $29.53 | $309,169 | 99,238 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-04-11 Exercise | 2025-04-14 5:17 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 6,075 | $0 | 12,119 (Direct) | View |
| 2025-04-11 Tax Withholding | 2025-04-14 5:17 pm | N/A N/A | Alkermes plc. | ALKS | Lurker Nancy Director | 1,459 | $27 | 12,119 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 5:19 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 2,746 | $0 | 15,957 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 5:19 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 808 | $34.8 | 15,957 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 5:18 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 5,409 | $0 | 109,104 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 5:18 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 2,402 | $34.8 | 109,104 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 5:17 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 8,322 | $0 | 226,335 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 5:17 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 3,695 | $34.8 | 226,335 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 5:16 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 6,866 | $0 | 98,338 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 5:16 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,049 | $34.8 | 98,338 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 5:15 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 6,866 | $0 | 224,853 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 5:15 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 3,049 | $34.8 | 224,853 (Direct) | View |
| 2025-02-26 Exercise | 2025-02-28 5:14 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 5,617 | $0 | 165,050 (Direct) | View |
| 2025-02-26 Tax Withholding | 2025-02-28 5:14 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 2,494 | $34.8 | 165,050 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 6:39 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 15,121 | $0 | 215,817 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 6:39 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 6,714 | $35.32 | 215,817 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 6:39 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 18,432 | $0 | 214,217 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 6:39 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 8,185 | $35.32 | 214,217 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 6:38 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 5,398 | $0 | 12,284 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 6:38 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 1,655 | $35.32 | 12,284 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 6:37 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 12,934 | $0 | 156,723 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 6:37 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 5,741 | $35.32 | 156,723 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 6:36 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 13,517 | $0 | 102,683 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 6:36 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 6,003 | $35.32 | 102,683 (Direct) | View |
| 2025-02-22 Exercise | 2025-02-25 6:35 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 19,968 | $0 | 89,302 (Direct) | View |
| 2025-02-22 Tax Withholding | 2025-02-25 6:35 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 8,866 | $35.32 | 89,302 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 5:18 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 2,033 | $0 | 34,003 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-20 5:18 pm | N/A 2035-02-19 | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 24,252 | $0 | 34,003 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 5:18 pm | N/A N/A | Alkermes plc. | ALKS | Parisi Samuel Joseph VP, Finance (Interim PAO) | 706 | $35.9 | 34,003 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 5:17 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 6,354 | $0 | 163,308 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-20 5:17 pm | N/A 2035-02-19 | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 74,599 | $0 | 163,308 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 5:17 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 1,869 | $35.9 | 163,308 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 5:16 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 6,354 | $0 | 293,069 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-20 5:16 pm | N/A 2035-02-19 | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 94,683 | $0 | 293,069 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 5:16 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,822 | $35.9 | 293,069 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 5:15 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 6,354 | $0 | 144,235 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 5:15 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 1,869 | $35.9 | 144,235 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 5:14 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 8,896 | $0 | 310,159 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-20 5:14 pm | N/A 2035-02-19 | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 114,768 | $0 | 310,159 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 5:14 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 3,950 | $35.9 | 310,159 (Direct) | View |
| 2025-02-18 Exercise | 2025-02-20 5:13 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 8,896 | $0 | 166,401 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-20 5:13 pm | N/A 2035-02-19 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 94,683 | $0 | 166,401 (Direct) | View |
| 2025-02-18 Tax Withholding | 2025-02-20 5:13 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 3,950 | $35.9 | 166,401 (Direct) | View |
| 2025-02-19 Option Award | 2025-02-20 5:11 pm | N/A 2035-02-19 | Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc | 293,921 | $0 | 293,921 (Direct) | View |
| 2025-02-12 Exercise | 2025-02-14 5:12 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 343,615 | $0 | 179,151 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-14 5:12 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 35,586 | $24.59 | 179,151 (Direct) | View |
| 2025-02-13 Exercise | 2025-02-14 5:12 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 108,833 | $31.93 | 179,151 (Direct) | View |
| 2025-02-12 Exercise | 2025-02-14 5:12 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 111,630 | $19.34 | 179,151 (Direct) | View |
| 2025-02-12 Exercise | 2025-02-14 5:12 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 87,566 | $20.03 | 179,151 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 8:36 pm | N/A N/A | Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc | 190,640 | $0 | 1,290,390 (Direct) | View |
| 2025-02-06 Tax Withholding | 2025-02-07 8:36 pm | N/A N/A | Alkermes plc. | ALKS | POPS RICHARD F Director and CEO, Alkermes plc | 79,925 | $31.39 | 1,290,390 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 8:35 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 24,565 | $0 | 77,869 (Direct) | View |
| 2025-02-06 Tax Withholding | 2025-02-07 8:35 pm | N/A N/A | Alkermes plc. | ALKS | Nichols Christian Todd SVP, Chief Commercial Officer | 7,399 | $31.39 | 77,869 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 8:33 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 34,393 | $0 | 181,548 (Direct) | View |
| 2025-02-06 Tax Withholding | 2025-02-07 8:33 pm | N/A N/A | Alkermes plc. | ALKS | Jackson Blair Curtis EVP, Chief Operating Officer | 10,647 | $31.39 | 181,548 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 8:31 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 34,393 | $0 | 63,600 (Direct) | View |
| 2025-02-06 Tax Withholding | 2025-02-07 8:31 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 15,083 | $31.39 | 63,600 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 8:30 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 32,350 | $0 | 188,499 (Direct) | View |
| 2025-02-06 Tax Withholding | 2025-02-07 8:30 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 9,752 | $31.39 | 188,499 (Direct) | View |
| 2025-02-06 Option Award | 2025-02-07 8:29 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 24,565 | $0 | 133,395 (Direct) | View |
| 2025-02-06 Tax Withholding | 2025-02-07 8:29 pm | N/A N/A | Alkermes plc. | ALKS | Brown Iain Michael SVP, Chief Financial Officer | 7,514 | $31.39 | 133,395 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-31 8:42 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 97,632 | $0 | 492,619 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-31 8:42 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 23,542 | $24.59 | 492,619 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-31 8:42 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 26,589 | $19.34 | 492,619 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-31 8:42 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 18,345 | $26.82 | 492,619 (Direct) | View |
| 2025-01-30 Exercise | 2025-01-31 8:42 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 29,156 | $20.03 | 492,619 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 48,997 | $0 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,044 | $24.59 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,090 | $19.34 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,411 | $26.82 | 593,537 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:53 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 12,452 | $20.03 | 593,537 (Direct) | View |
| 2024-12-08 Exercise | 2024-12-09 8:51 pm | N/A N/A | Alkermes plc. | ALKS | LAURENCIN CATO T Director | 6,854 | $0 | 39,155 (Direct) | View |
| 2024-12-09 Exercise | 2024-12-09 8:51 pm | N/A N/A | Alkermes plc. | ALKS | LAURENCIN CATO T Director | 2,691 | $22.52 | 39,155 (Direct) | View |
| 2024-12-08 Tax Withholding | 2024-12-09 8:51 pm | N/A N/A | Alkermes plc. | ALKS | LAURENCIN CATO T Director | 958 | $31.46 | 39,155 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 4:48 pm | N/A 2030-02-20 | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 43,058 | $0 | 212,474 (Direct) | View |
| 2024-11-11 Exercise | 2024-11-12 4:48 pm | N/A N/A | Alkermes plc. | ALKS | Hopkinson Craig C. EVP R&D, Chief Medical Officer | 43,058 | $20.03 | 212,474 (Direct) | View |
| 2024-08-03 Exercise | 2024-08-05 4:13 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 2,014 | $0 | 169,930 (Direct) | View |
| 2024-08-03 Tax Withholding | 2024-08-05 4:13 pm | N/A N/A | Alkermes plc. | ALKS | Gaffin David Joseph EVP, CLO, Alkermes, Inc. | 895 | $27.72 | 169,930 (Direct) | View |
| 2024-06-29 Exercise | 2024-07-01 5:04 pm | N/A N/A | Alkermes plc. | ALKS | Wright Christopher I Director | 6,104 | $0 | 14,416 (Direct) | View |
| 2024-06-29 Tax Withholding | 2024-07-01 5:04 pm | N/A N/A | Alkermes plc. | ALKS | Wright Christopher I Director | 1,465 | $24.1 | 14,416 (Direct) | View |
| 2024-06-29 Exercise | 2024-07-01 5:02 pm | N/A N/A | Alkermes plc. | ALKS | Wilson Frank Anders Director | 6,104 | $0 | 24,995 (Direct) | View |
| 2024-06-29 Tax Withholding | 2024-07-01 5:02 pm | N/A N/A | Alkermes plc. | ALKS | Wilson Frank Anders Director | 1,465 | $24.1 | 24,995 (Direct) | View |
| 2024-06-29 Exercise | 2024-07-01 5:01 pm | N/A N/A | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 6,104 | $0 | 25,422 (Direct) | View |
| 2024-06-29 Tax Withholding | 2024-07-01 5:01 pm | N/A N/A | Alkermes plc. | ALKS | snyderman nancy lynn MD Director | 1,465 | $24.1 | 25,422 (Direct) | View |
| 2024-06-29 Exercise | 2024-07-01 4:59 pm | N/A N/A | Alkermes plc. | ALKS | MCKEON BRIAN P Director | 6,104 | $0 | 37,780 (Direct) | View |
| 2024-06-29 Tax Withholding | 2024-07-01 4:59 pm | N/A N/A | Alkermes plc. | ALKS | MCKEON BRIAN P Director | 1,465 | $24.1 | 37,780 (Direct) | View |